Evidence map›Paper›PMID 27129207›Full record

ArticleThe Journal of biological chemistry2016

Rearrangement of the Extracellular Domain/Extracellular Loop 1 Interface Is Critical for Thyrotropin Receptor Activation.

Joerg Schaarschmidt, Marcus B M Nagel, Sandra Huth, Holger Jaeschke, Rocco Moretti, Vera Hintze, Martin von Bergen, Stefan Kalkhof, Jens Meiler, Ralf Paschke

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. TSHR as a therapeutic target in Graves' disease.Expert opinion on therapeutic targets · 2017
    Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Joerg SchaarschmidtDepartment of Internal Medicine, University of Leipzig, 04103 Leipzig, Germany.
Marcus B M NagelDepartment of Internal Medicine, University of Leipzig, 04103 Leipzig, Germany,; Department of Proteomics, Helmholtz-Centre for Environmental Research, 04318 Leipzig, Germany.
Sandra HuthDepartment of Internal Medicine, University of Leipzig, 04103 Leipzig, Germany.
Holger JaeschkeDepartment of Internal Medicine, University of Leipzig, 04103 Leipzig, Germany.
Rocco MorettiDepartment of Chemistry and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee 37235.
Vera HintzeInstitute of Materials Science, Max Bergmann Center of Biomaterials, TU Dresden, 01069 Dresden, Germany.
Martin von BergenDepartment of Proteomics, Helmholtz-Centre for Environmental Research, 04318 Leipzig, Germany,; Faculty of Biosciences, Pharmacy and Psychology, Institute of Biochemistry, University of Leipzig, 04103 Leipzig, Germany,; Aalborg University, Department of Chemistry and Bioscience, Fredrik Bajers Vej 7, 9220 Aalborg, Denmark.
Stefan KalkhofDepartment of Proteomics, Helmholtz-Centre for Environmental Research, 04318 Leipzig, Germany,; Department of Bioanalytics, University of Applied Sciences and Arts of Coburg, 96450 Coburg, Germany.
Jens MeilerDepartment of Chemistry and Center for Structural Biology, Vanderbilt University, Nashville, Tennessee 37235.
Ralf PaschkeDivision of Endocrinology and Metabolism and Arnie Charbonneau Cancer Institute University of Calgary, Calgary, Alberta T2N 1N4, Canada. Electronic address: ralf.paschke@ucalgary.ca.
Helmholtz Centre for Environmental Research · DELeipzig University of Applied Sciences · DEVanderbilt University · USMax Bergmann Zentrum für Biomaterialien · DEUniversity of Calgary · CA

Funding

GPU-Accelerated Parallel Computer for Drug Discovery ApplicationsS10OD020154 · OD · VANDERBILT UNIVERSITY · PI SMITH, JARROD ANSON · 2015 to 2015
$225k
6 · The paper itself

Abstract

The thyroid stimulating hormone receptor (TSHR) is a G protein-coupled receptor (GPCR) with a characteristic large extracellular domain (ECD). TSHR activation is initiated by binding of the hormone ligand TSH to the ECD. How the extracellular binding event triggers the conformational changes in the transmembrane domain (TMD) necessary for intracellular G protein activation is poorly understood. To gain insight in this process, the knowledge on the relative positioning of ECD and TMD and the conformation of the linker region at the interface of ECD and TMD are of particular importance. To generate a structural model for the TSHR we applied an integrated structural biology approach combining computational techniques with experimental data. Chemical cross-linking followed by mass spectrometry yielded 17 unique distance restraints within the ECD of the TSHR, its ligand TSH, and the hormone-receptor complex. These structural restraints generally confirm the expected binding mode of TSH to the ECD as well as the general fold of the domains and were used to guide homology modeling of the ECD. Functional characterization of TSHR mutants confirms the previously suggested close proximity of Ser-281 and Ile-486 within the TSHR. Rigidifying this contact permanently with a disulfide bridge disrupts ligand-induced receptor activation and indicates that rearrangement of the ECD/extracellular loop 1 (ECL1) interface is a critical step in receptor activation. The experimentally verified contact of Ser-281 (ECD) and Ile-486 (TMD) was subsequently utilized in docking homology models of the ECD and the TMD to create a full-length model of a glycoprotein hormone receptor.

Indexed as

AnimalsCHO CellsCricetinaeCricetulusGlycosylationHumansMass SpectrometryModels, MolecularMutationProteolysisReceptors, ThyrotropinSurface Plasmon ResonanceReceptors, Thyrotropincell signalingcomputer modelingG protein-coupled receptor (GPCR)mass spectrometry (MS)protein cross-linkingreceptor structure-functionsite-directed mutagenesisstructural biologysurface plasmon resonance (SPR)

Identifiers

PMID27129207
PMCPMC4933169
OpenAlexW2344414687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.